ATE159172T1 - Peptide und deren verwendung - Google Patents
Peptide und deren verwendungInfo
- Publication number
- ATE159172T1 ATE159172T1 AT91915658T AT91915658T ATE159172T1 AT E159172 T1 ATE159172 T1 AT E159172T1 AT 91915658 T AT91915658 T AT 91915658T AT 91915658 T AT91915658 T AT 91915658T AT E159172 T1 ATE159172 T1 AT E159172T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- glu
- pct
- acid residue
- residue selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9002684A SE9002684D0 (sv) | 1990-08-17 | 1990-08-17 | New peptides and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE159172T1 true ATE159172T1 (de) | 1997-11-15 |
Family
ID=20380175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91915658T ATE159172T1 (de) | 1990-08-17 | 1991-08-16 | Peptide und deren verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5609872A (de) |
| EP (1) | EP0544781B1 (de) |
| AT (1) | ATE159172T1 (de) |
| AU (1) | AU656914B2 (de) |
| CA (1) | CA2089660A1 (de) |
| DE (1) | DE69127974T2 (de) |
| SE (1) | SE9002684D0 (de) |
| WO (1) | WO1992003159A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2337754C (en) | 1998-08-21 | 2011-05-24 | Altaf A. Lal | Recombinant multivalent malarial vaccine against plasmodium falciparum |
| FR2822834B1 (fr) * | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
| FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
| JP4698950B2 (ja) * | 2002-04-09 | 2011-06-08 | フラメル・テクノロジー | アモキシシリンの改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤 |
| EP1492511B3 (de) | 2002-04-09 | 2012-05-02 | Flamel Technologies | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
| FR2840614B1 (fr) | 2002-06-07 | 2004-08-27 | Flamel Tech Sa | Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques |
| FR2843117B1 (fr) * | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques |
| FR2855521B1 (fr) * | 2003-05-28 | 2005-08-05 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques. |
| FR2860516B1 (fr) * | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
| FR2862536B1 (fr) * | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01500827A (ja) * | 1986-07-17 | 1989-03-23 | サラマン・プロプライエタリー・リミテッド | プラスモジウム・ファルシパルムの低分子量抗原 |
| US4957738A (en) * | 1987-01-14 | 1990-09-18 | Patarroyo Manuel E | Protein copolymer malaria vaccine |
-
1990
- 1990-08-17 SE SE9002684A patent/SE9002684D0/xx unknown
-
1991
- 1991-08-16 AT AT91915658T patent/ATE159172T1/de active
- 1991-08-16 US US07/969,305 patent/US5609872A/en not_active Expired - Fee Related
- 1991-08-16 WO PCT/SE1991/000541 patent/WO1992003159A1/en not_active Ceased
- 1991-08-16 CA CA002089660A patent/CA2089660A1/en not_active Abandoned
- 1991-08-16 DE DE69127974T patent/DE69127974T2/de not_active Expired - Fee Related
- 1991-08-16 EP EP91915658A patent/EP0544781B1/de not_active Expired - Lifetime
- 1991-08-16 AU AU83985/91A patent/AU656914B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0544781B1 (de) | 1997-10-15 |
| AU8398591A (en) | 1992-03-17 |
| AU656914B2 (en) | 1995-02-23 |
| DE69127974T2 (de) | 1998-02-12 |
| US5609872A (en) | 1997-03-11 |
| CA2089660A1 (en) | 1992-02-18 |
| WO1992003159A1 (en) | 1992-03-05 |
| EP0544781A1 (de) | 1993-06-09 |
| DE69127974D1 (de) | 1997-11-20 |
| SE9002684D0 (sv) | 1990-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9304089A (es) | Uso de gm-csf como una vacuna adyuvante. | |
| ATE413189T1 (de) | Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1 | |
| ES2100240T3 (es) | Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen. | |
| PT82975A (en) | Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein and of vaccine against the malaria | |
| DK0689449T3 (da) | Præparater til anvendelse i humanterapi, kendetegnet ved kombination af et muramylpeptid med en cytokin | |
| ATE159172T1 (de) | Peptide und deren verwendung | |
| ATE169638T1 (de) | Analoge des menschlichen interleukin-8. | |
| CA2169297A1 (en) | Protein- or peptide-cochleate vaccines and methods of immunizing using the same | |
| GB9219936D0 (en) | Vaccines | |
| NZ243167A (en) | Protein with one or more immunogenic determinants of an eimeria antigen and its production and use | |
| ES2131528T3 (es) | Nuevos polipeptidos y su uso. | |
| DK0491628T3 (da) | Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner | |
| MX9300787A (es) | Peptido para diagnosticar e inmunizar contra la infeccion por t. cruzi. | |
| DK0425082T3 (da) | Vacciner | |
| PT787796E (pt) | Epitopos protectores de ciclase do adenilo-hemolisina (ac-hly), sua aplicação ao tratamento ou à prevenção das infecções por bordetella | |
| DE59107665D1 (de) | Protektive Plasmodium falciparum Hybridproteine, die Teilsequenzen der Malaria-Antigene HRPII und SERP enthalten | |
| ZA914227B (en) | Novel protein | |
| IT1217314B (it) | Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale | |
| DK204588A (da) | Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider | |
| WO1994004565A3 (en) | Ipnv vaccine | |
| ZA896942B (en) | Allelic variants of plasmodium falciparum merozoite surface antigen | |
| ZA888580B (en) | New immunologically active synthetic peptides useful for preparing an antimalarial vaccine | |
| MY106940A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. |